1. Insempra, a German biotechnology company, has raised $20 million in a Series A funding round. The company plans to use the funds to develop its eco-friendly lipid production technology, which aims to provide a sustainable alternative to traditional lipid sources. Insempra's technology utilizes microalgae to produce high-quality lipids for various applications, including food, cosmetics, and pharmaceuticals.

2. The Series A funding was led by Venture Capital firm Capricorn Partners, with participation from existing investors such as High-Tech Gründerfonds and Innovationsstarter Fonds Hamburg. The investment will allow Insempra to scale up its production capacity and further refine its technology, with the goal of bringing its lipid products to market in the near future.

3. Insempra's technology is based on the efficient cultivation of microalgae, which are capable of producing lipids through photosynthesis. By harnessing the natural capabilities of these microorganisms, Insempra aims to create a more sustainable and environmentally-friendly source of lipids compared to traditional methods that rely on animal fats or plant-based oils. The company's technology has the potential to contribute to the transition towards a more sustainable and circular economy.